Works matching IS 13520504 AND DT 2015 AND VI 22 AND IP 8

Results: 9

A randomized, placebo-controlled study of the NS5B inhibitor beclabuvir with peginterferon/ribavirin for HCV genotype 1.

Published in:

Journal of Viral Hepatitis, 2015, v. 22, n. 8, p. 658, doi. 10.1111/jvh.12372

By:

Tatum, H.;
Thuluvath, P. J.;
Lawitz, E.;
Martorell, C.;
DeMicco, M.;
Cohen, S.;
Rustgi, V.;
Ravendhran, N.;
Ghalib, R.;
Hanson, J.;
Zamparo, J.;
Zhao, J.;
Cooney, E.;
Treitel, M.;
Hughes, E.

Publication type:

Article

Simeprevir added to peginterferon and ribavirin lessens time with fatigue, depressive symptoms and functional limitations in patients with chronic hepatitis C compared with peginterferon and ribavirin: results from 1161 patients in the QUEST-1, QUEST-2 and PROMISE studies

Published in:

Journal of Viral Hepatitis, 2015, v. 22, n. 8, p. 639, doi. 10.1111/jvh.12365

By:

Scott, J.;
Gilles, L.;
Fu, M.;
Brohan, E.;
Panter, C.;
Arbuckle, R.;
Jessner, W.;
Beumont, M.

Publication type:

Article

Clinical impact of treatment timing for chronic hepatitis C infection: a decision model.

Published in:

Journal of Viral Hepatitis, 2015, v. 22, n. 8, p. 630, doi. 10.1111/jvh.12412

By:

Pho, M. T.;
Jensen, D. M.;
Meltzer, D. O.;
Kim, A. Y.;
Linas, B. P.

Publication type:

Article

Tenofovir-based alternate therapies for chronic hepatitis B patients with partial virological response to entecavir.

Published in:

Journal of Viral Hepatitis, 2015, v. 22, n. 8, p. 675, doi. 10.1111/jvh.12368

By:

Lu, L.;
Yip, B.;
Trinh, H.;
Pan, C. Q.;
Han, S.‐H. B.;
Wong, C. C.;
Li, J.;
Chan, S.;
Krishnan, G.;
Nguyen, M. H.

Publication type:

Article

Oral anti-CD3 immunotherapy for HCV-nonresponders is safe, promotes regulatory T cells and decreases viral load and liver enzyme levels: results of a phase-2a placebo-controlled trial.

Published in:

Journal of Viral Hepatitis, 2015, v. 22, n. 8, p. 651, doi. 10.1111/jvh.12369

By:

Halota, W.;
Ferenci, P.;
Kozielewicz, D.;
Dybowska, D.;
Lisovoder, N.;
Samira, S.;
Shalit, I.;
Ellis, R.;
Ilan, Y.

Publication type:

Article

Cognitive function and endogenous cytokine levels in children with chronic hepatitis C.

Published in:

Journal of Viral Hepatitis, 2015, v. 22, n. 8, p. 665, doi. 10.1111/jvh.12373

By:

Abu Faddan, N. H.;
Shehata, G. A.;
Abd Elhafeez, H. A.;
Mohamed, A. O.;
Hassan, H. S.;
Abd El Sameea, F.

Publication type:

Article

HCV: the best cure possible or the best possible cure?

Published in:

Journal of Viral Hepatitis, 2015, v. 22, n. 8, p. 627, doi. 10.1111/jvh.12411

By:

Craxì, L.;
Cammà, C.;
Craxì, A.

Publication type:

Article

Role of complement component C4 in treatment response and disease progression in chronic hepatitis C patients.

Published in:

Journal of Viral Hepatitis, 2015, v. 22, n. 8, p. 671, doi. 10.1111/jvh.12383

By:

Chowdhury, S. J.;
Karra, V. K.;
Bharali, R.;
Kar, P.

Publication type:

Article

'HepConomics': cost-effective, indeed, but how can we pay for it?

Published in:

Journal of Viral Hepatitis, 2015, v. 22, n. 8, p. 682, doi. 10.1111/jvh.12396

By:

Athanasakis, K.;
Petrakis, I.;
Kyriopoulos, J.

Publication type:

Article